Increased levels of CSF2RA and GM-CSF signaling have been observed in hematologic malignancies such as CMML (chronic myelomonocytic leukemia) and JMML (juvenile myelomonocytic leukemia) [60, 61]. The gene discussed is CSF2RA; the disease is juvenile myelomonocytic leukemia.